Valuation : BICO Group AB

Market Cap 1.58B 164M 142M 134M 122M 227M 15.52B 229M 614M 7.94B 617M 604M 26.07B P/E 2026 *
-6.96x
P/E 2027 * -12.5x
Enterprise Value 1.51B 157M 136M 128M 116M 217M 14.84B 219M 587M 7.59B 590M 577M 24.93B EV / Sales 2026 *
0.93x
EV / Sales 2027 * 0.84x
Free-Float
69.88%
Yield 2026 *
-
Yield 2027 * -
1 week+14.40%
Current month+4.59%
1 month+55.07%
3 months+24.70%
6 months+22.10%
Current year+6.22%
1 week 1.74
Extreme 1.74
2.05
1 month 1.31
Extreme 1.314
2.05
3 years 1.17
Extreme 1.172
6.4
5 years 1.17
Extreme 1.172
60.9
Manager TitleAgeSince
Chief Executive Officer 51 2026-08-31
Director of Finance/CFO 56 2026-02-28
Chief Operating Officer - 2026-01-06
Director TitleAgeSince
Director/Board Member 70 2019-12-17
Director/Board Member 37 2015-02-28
Director/Board Member - 2026-05-06
Change 5-day change 1-year change 3-year change Capi.($)
+3.96%+9.43%-3.57%-46.49% 164M
+1.34%-3.12%+23.51%+9.21% 222B
+1.44%-2.81%+1.99%-20.96% 145B
+0.71%+0.01%-21.43%+19.80% 130B
+0.60%-2.99%-54.15%-9.79% 69.68B
+0.09%-0.06%+11.65%+18.91% 52.3B
+0.41%-0.60%-17.27%-13.84% 50.71B
+0.97%-2.18%+20.48%+24.18% 42.28B
+1.57%-0.54%+36.58%+46.68% 39.87B
-0.21%-2.42%-15.90%+45.03% 33.37B
Average +0.77%-1.55%-1.81%+7.27% 87.35B
Weighted average by Cap. +0.97%-2.12%+0.59%+7.07%

Financials

2026 *2027 *
Net sales 1.62B 169M 145M 137M 125M 233M 15.93B 235M 629M 8.14B 633M 619M 26.75B 1.69B 175M 151M 142M 130M 242M 16.55B 244M 654M 8.46B 658M 643M 27.79B
Net income -227M -23.59M -20.35M -19.17M -17.47M -32.65M -2.23B -32.9M -88.1M -1.14B -88.6M -86.66M -3.74B -126M -13.1M -11.3M -10.64M -9.7M -18.12M -1.24B -18.26M -48.9M -632M -49.18M -48.1M -2.08B
Net Debt -69M -7.17M -6.19M -5.83M -5.31M -9.93M -677M -10M -26.78M -346M -26.93M -26.34M -1.14B -166M -17.25M -14.88M -14.02M -12.78M -23.88M -1.63B -24.06M -64.42M -833M -64.79M -63.37M -2.74B
Logo BICO Group AB
BICO Group AB, previously Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Company develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.
Employees
-
Date Price Change
26-09-02 €2.050 +3.96%
26-09-01 €1.972 +0.61%
26-08-31 €1.960 +3.27%
26-08-28 €1.898 +5.68%
26-08-27 €1.796 +0.22%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
22.40SEK
Average target price
29.00SEK
Spread / Average Target
+29.46%

Quarterly revenue - Rate of surprise